Latest news

NZSO Skin cancer

Skin Cancer Research Review

NZSO ANZCCART conference image w sheep 2

ANZCCART 2021 | 25th-27th July | Queenstown

NZSO ministry of education

Draft content for each NCEA Level 1 subject

Welcome to the sixth issue of Skin Cancer Research Review.

This issue includes research reporting that patients who relapse after adjuvant targeted therapy for BRAFmutated stage III melanoma respond well to subsequent anti-PD-1-based therapy with outcomes similar to those seen with first-line anti-PD-1 therapy for stage IV melanoma. We have also included a long-term safety report from three of the KEYNOTE trials of pembrolizumab monotherapy for melanoma. Research conducted in participants from a dermoscopy masterclass found that the accuracy of diagnosing lentigo maligna improved after they were trained in the inverse approach, added to the classic pattern analysis. This issue concludes with an Australian study investigating discrepancies between biopsy results and final excised specimens in keratinocyte carcinomas.

We hope you enjoy the research selected, and we look forward to your comments and feedback.

Kind regards,
Dr Annie Wong

New Fellowship, Ngā Ahurei a Te Apārangi, and Honorary Fellowship, Ngā Ahurei Honore a Te Apārangi

The Academy of the Royal Society Te Apārangi is today calling for new Fellowship, Ngā Ahurei a Te Apārangi, and Honorary Fellowship, Ngā Ahurei Honore a Te Apārangi, nominations for 2021.

Fellowshipof the Royal Society of New Zealand is an honour proposed by one’s peers and conferred for distinction in research or the outcomes resulting from intellectual endeavour (Advancement).

A web portal has been set up to receive new and updated nominations, so please email ( if you wish to submit a new nomination and you will be provided with a URL to access the web portal. Details of the nomination process and requirements can be found here, and the closing date is 30 June 2021.

Please note that the Academy is focused on increasing the diversity of nominations from under-represented groups, particularly with respect to gender, ethnicity, and employment context.

Nau mai, haere mai, welcome to ANZCCART 2021. 25th-27th July, Queenstown.

This year’s conference looks at ‘openness’ in animal research and teaching. Public confidence in animal research hinges on the scientific community engaging in the evolving conversation about how and why animals are used. Being open about these matters is a worthwhile endeavour, and to be encouraged.

To gain a broader perspective on how openness looks in practise, we will examine overseas examples, both success stories and failures, and learn from different cultural viewpoints.

We anticipate that the adoption of new approaches to openness will reflect constructively on ANZCCART‘s principal objectives, particularly the Three R’s – the refinement, reduction and replacement of animals in research and teaching.

The NZ Ministry of Education has released the draft content for each NCEA Level 1 subject:

  • Learning Matrices – a new product which identify and describe the significant learning of subjects that can be used to develop robust teaching and learning programmes.
  • Assessment Matrices – which identify the significant learning that will be assessed and credentialed at each NCEA level.
  • Course Outlines – which provide examples of how significant learning can inform a year of teaching and learning.
  • Initial draft Teaching, Learning and Assessment guides – which provide the overarching framework and structure to the assessment package, detailing links between The New Zealand Curriculum and the assessment at NCEA level.

Feedback can be provided through online questionnaires until 19 April 2021:

Questionnaire in English

Questionnaire in te reo Māori

Draft NCEA Level 1 achievement standards and assessment activities will be developed from May to August 2021, when feedback will be sought on this content.

More information is available on the NCEA Education website. If you have any queries in the meantime, please email us at

Are you a doctor, nurse or allied healthcare professional working in Aotearoa?

We invite Maori and non-Maori healthcare professionals who have provided care for patients with cancer to take part in a brief online survey. iPad Mini up for grabs.

Click here to start the survey.

The call for nominations for medals and awards for the 2021 round is now open.

Please note that the Academy Executive Committee is focused on increasing the diversity of nominations from under-represented groups, particularly with respect to gender, ethnicity and employment context, from Crown Research Institutes and Independent Research organisations.

Podcast episode featuring Diana Safartis

Please see below the podcast episode featuring a really in-depth interview with Diana Safarti, discussing Global Disparity of Cancer Care and specifically in the Pacific. Here’s the link for you to listen:

To subscribe to Oncology News Australia, which includes a mix of conference coverage, reviews, news, opinion pieces, podcasts –

NZSO Openness Agreement

Openness Agreement on the use of animals in research and teaching in New Zealand

Foreword from Professor Juliet Gerrard, The Prime Minister’s Chief Science Advisor:

Why the Openness Agreement was developed?

The Australia New Zealand Council for the Care of Animals in Research and Teaching (ANZCCART) is an independent body that was established to provide a focus for consideration of the scientific, ethical and social issues associated with the use of animals in research and teaching. After years of promoting openness in animal research, ANZCCART has taken the lead in developing this Agreement

Job Description: Home-based Flexible Hours Position - currently Auckland-based, but could be elsewhere in New Zealand.

We are calling for expressions of interest for the role of General Manager for Cancer Research Trust NZ (CRTNZ) to replace Dr Douglas Ormrod who is retiring.

CRTNZ is an independent registered charity founded in 2001. Its key purpose is to raise and distribute funds to New Zealand’s top cancer research scientists and clinicians to undertake leading-edge research and professional development. To date more than $18 million has been distributed and CRTNZ is New Zealand’s second largest non-government funder of cancer research.

We support research and professional development across the cancer-control spectrum so that significant advances continue to be made in understanding, prevention, diagnosis and treatment of cancer, as well as in end-of-life care.

The General Manager will have a background in laboratory and/or clinical cancer research or a related discipline (such as public health or pathology), preferably at PhD level. Research management experience would also be an advantage. Their core responsibility is to liaise between the research community and the CRTNZ Assessment Committee and Board, and to manage the rigorous peer review process that underpins the success of the Trust’s grant award programme. This is a sole charge position. As well as processing the research grant rounds the General Manager will be responsible for managing the financial administration of the Trust’s operation. The role entails working with people at all levels across local and international academia.

The successful applicant’s responsibilities include:

  • Managing the grant review and research funding process
  • Contracting and monitoring research outputs
  • Paying the monthly accounts using Xero software
  • Liaising with the Trust’s accountant and overseeing the annual financial audit
  • Promotion of the Trust via social media and other platforms
  • Managing the web site, donor database and other fundraising platforms
  • Preparing lay stories based on research outcomes for public consumption.

Our values of respect, sustainability, collaboration, and transparency underpin our work. For further information regarding the history and work of CRTNZ visit

If you would like to know more about this rewarding position please email the Executive Director Douglas Ormrod for a job description or Phone: 22 079 3349 in confidence. Expressions of interest are to be forwarded to along with a Curriculum Vitae on or before 26th February 2021. Interviews will be held in Auckland thereafter, or by zoom if necessary.

NZSO Latest news TRY

ACORD21 will be held virtually

29 August - 3 September 2021

For all interested parties including medical oncology, haematology, radiation oncology trainees, nursing staff and others interested in oncology research to apply for this excellent opportunity.

Applications are open for the ACORD Protocol Development Workshop 2021 which is a 1-week program in effective clinical trial design for early career clinical cancer researchers from all oncology sub-specialties based in the Asia Pacific region. Come with a trial concept, leave with a trial protocol.

Applications close: 22 March 2021 12pm AEST

More information:

Any queries to be sent to Dr Nicky Lawrence, MBChB, PhD, FRACP,

Important research featured on Newshub

from our very own Executive Member, Associate Professor Logan Walker

Click here to see the importance of mandatory genetic screenings for women diagnosed with breast cancer.

NZSO Loganwalker news
NRHC Roslyn Kemp

Roslyn Kemp, NZSO's immediate past President, has been promoted as a professor at the University of Otago!

Congratulations from all of us at NZSO!

2021 New Zealand Annual Scientific Meeting

On behalf of the Royal Australian and New Zealand College of Radiologists (RANZCR) and the 2021 NZ ASM Organising Committee, we are happy to confirm

Friday 6 - Sunday 8 August 2021 | The InterContinental Hotel | Wellington, New Zealand

Given the continuing restrictions on international travel, our overseas speakers have confirmed that they will join us remotely – with pre-recorded presentations and then real-time participation with delegates for live Q & A:


Professor Laurie A. Loevner, Chief, Division of Neuroradiology, Professor of Radiology, Neurosurgery, Otorhinolaryngology: Head & Neck Surgery and Ophthalmology, University of Pennsylvania Health System, USA.
Specialty Interests: Head and Neck, Neuroradiology

Associate Professor Bruno Giuffrè, University of Sydney at Northern Clinical School, Radiology Department, Royal North Shore Hospital, Sydney, Australia.
Specialty Interests: Musculoskeletal, RheumatologyAssociate

Radiation Oncology

Associate Professor Corrine Doll, Tom Baker Cancer Center, President of Canadian Association of Radiation Oncology, Calgary, Canada.
Specialty Interests: Gynecologic, Gastrointestinal Cancer Rheumatology

Registration and Abstract Submissions open on 8 April. For more information:

NZSO RANZCR Illustrated Logo 01

Cancer Research Trust New Zealand

Special Call for applications for Cooperative Group Clinical Trails and Public Health Research

Cancer Research Trust NZ (CRTNZ) funds research across the Cancer Control spectrum, from prevention, through diagnosis and treatment to end of life care.

CRTNZ is offering two $200k research project awards, one each in the fields of cancer-related Public Health and Cooperative Group Clinical Trials. Although this is a one-off initiative, it may be repeated in the future.

While it is envisaged that salary costs will be the major component of these awards (for Public Health in particular), expenses can also be included.

The awards will be for two years ($100k per year, per project) but could be over a longer period if necessary.

Applications should be made on the Research Project application form on the Trust’s web site and submitted by April 1st 2021. We are currently modifying the application form and this will be available in January 2021 . The peer-review period will depend on the number of applications received but will be no longer than 3 months.

To aid in planning please let Douglas Ormrod know if you are going to apply

NZSO cancer research trust